Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1CU Chemie Uetikon GmbH
01 1TERAZOSIN HYDROCHLORIDE ANHYDROUS
01 1France
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
TERAZOSIN HYDROCHLORIDE ANHYDROUS
NDC Package Code : 54382-116
Start Marketing Date : 1991-08-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Terazosin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terazosin, including repackagers and relabelers. The FDA regulates Terazosin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terazosin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terazosin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terazosin supplier is an individual or a company that provides Terazosin active pharmaceutical ingredient (API) or Terazosin finished formulations upon request. The Terazosin suppliers may include Terazosin API manufacturers, exporters, distributors and traders.
click here to find a list of Terazosin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Terazosin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Terazosin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Terazosin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Terazosin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Terazosin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Terazosin suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
